cemagraphics/E+ via Getty Images At the risk of sounding like a Cassandra, I think today's market decline portends even lower prices going forward. It's not the magnitude of the decline that I'm concerned about, but the fact that we closed more than 5% below the all-time high for the S&P 500. That could be an important rubicon that we just crossed. The Drawdowns The clearest picture I have of the ...
cemagraphics/E+ via Getty Images At the risk of sounding like a Cassandra, I think today's market decline portends even lower prices going forward. It's not the magnitude of the decline that I'm concerned about, but the fact that we closed more than 5% below the all-time high for the S&P 500. That could be an important rubicon that we just crossed. The Drawdowns The clearest picture I have of the smooth sailing we have been experiencing until recently is displayed below. The drawdown may only be 5.1%, but that's enough to get market technicians all riled up. And this is a critical moment when the dip-buyers have faithfully shown up for the past year. Will they show up tomorrow? Other Indicators Are Flashing Yellow The next chart shows the narrowing of the spread between the short-term (50-day) and long-term (200-day) moving averages. This narrowing began in early December last year, and it's picking up speed now. If the 50-day should cross below the 200-day, that would be what technicians call a "Death Cross." (A little too dramatic for my taste, but you get the point.) This Is Where We Are Today We've covered the drawdown and the moving average narrowing, and now I'd like to point out that we have broken key support (6695 on the S&P 500). When this happens, the market often continues to decline until it finds a level where investors can no longer resist the temptation to buy the dip. Also note that we are within 0.1% of the 200-day moving average - another psychological support level. Bollinger Bands Widening Sharply Bollinger bands are another way to gauge the level and trend of market volatility. The higher the bandwidth, the higher the daily swings in the market. Just in the last week, we have gone from under 3% to over 6%. That's a significant move for this indicator. Danger Zone Chart This chart looks a little busy, but it has something important to tell us. I have noticed over the years that when the market drops below its level from one year ago, it often sp...
Preferred Bank ( PFBC ) declares $0.80/share quarterly dividend . Forward yield 3.67% Payable April 21; for shareholders of record April 7; ex-div April 7. See PFBC Dividend Scorecard, Yield Chart, & Dividend Growth. More on Preferred Bank Preferred Bank (PFBC) Q4 2025 Earnings Call Transcript Preferred Bank: Quality On The Cheap Seeking Alpha’s Quant Rating on Preferred Bank Historical earnings d...
Preferred Bank ( PFBC ) declares $0.80/share quarterly dividend . Forward yield 3.67% Payable April 21; for shareholders of record April 7; ex-div April 7. See PFBC Dividend Scorecard, Yield Chart, & Dividend Growth. More on Preferred Bank Preferred Bank (PFBC) Q4 2025 Earnings Call Transcript Preferred Bank: Quality On The Cheap Seeking Alpha’s Quant Rating on Preferred Bank Historical earnings data for Preferred Bank Dividend scorecard for Preferred Bank
CVS ( CVS ) declares $0.665/share quarterly dividend , in line with previous. Payable May 4; for shareholders of record April 23; ex-div April 23. See CVS Dividend Scorecard, Yield Chart, & Dividend Growth. More on CVS CVS Health Corporation (CVS) Presents at Leerink Global Healthcare Conference 2026 Transcript CVS Health: Stop Catastrophizing, Start Believing - Here's Why CVS Health: Why Margin C...
CVS ( CVS ) declares $0.665/share quarterly dividend , in line with previous. Payable May 4; for shareholders of record April 23; ex-div April 23. See CVS Dividend Scorecard, Yield Chart, & Dividend Growth. More on CVS CVS Health Corporation (CVS) Presents at Leerink Global Healthcare Conference 2026 Transcript CVS Health: Stop Catastrophizing, Start Believing - Here's Why CVS Health: Why Margin Compression In Aetna Limits The Upside For 2026 CVS Health to pay $117.7M to settle Medicare fraud allegations Extra premiums due to alleged Medicare overpayments topped $13B in 2025: WSJ